| Product NDC: | 0019-1324 |
| Proprietary Name: | Optiray |
| Non Proprietary Name: | Ioversol |
| Active Ingredient(s): | 509 mg/mL & nbsp; Ioversol |
| Administration Route(s): | INTRA-ARTERIAL; INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0019-1324 |
| Labeler Name: | Mallinckrodt Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019710 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120304 |
| Package NDC: | 0019-1324-78 |
| Package Description: | 20 SYRINGE, PLASTIC in 1 CARTON (0019-1324-78) > 50 mL in 1 SYRINGE, PLASTIC |
| NDC Code | 0019-1324-78 |
| Proprietary Name | Optiray |
| Package Description | 20 SYRINGE, PLASTIC in 1 CARTON (0019-1324-78) > 50 mL in 1 SYRINGE, PLASTIC |
| Product NDC | 0019-1324 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ioversol |
| Dosage Form Name | INJECTION |
| Route Name | INTRA-ARTERIAL; INTRAVENOUS |
| Start Marketing Date | 20120304 |
| Marketing Category Name | NDA |
| Labeler Name | Mallinckrodt Inc. |
| Substance Name | IOVERSOL |
| Strength Number | 509 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |